1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2022 - East Asia

Chronic Disease Analysis & Statistics 2022 - East Asia

1-8 of 8 reports

Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $ 2000
  • March 2022
  • 39 pages

Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism ...

  • World
  • South Korea
  • Cardiovascular Disease
  • Blood Disease
  • Investor presentation
  • Company

Company Analysis: AstraZeneca

  • $ 3000
  • January 2021
  • 87 pages

PharmaVitae explores AstraZeneca’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – AstraZeneca is poised for continued growth, driven by its oncology portfolio ...

  • World
  • China
  • Lung Cancer
  • Prescription Drug
  • Company research
  • Company

Grifols SA (GRF) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 75 pages

Summary Grifols SA (Grifols) is a pharmaceutical and chemical manufacturer that focuses on enhancing the health and well-being of people around the world.It conducts research, development, manufacturing ...

  • World
  • United States
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Company research
  • Company
  • Biologics Sales
  • Drug Approval

Astellas Company Analysis

  • $ 3000
  • September 2018
  • 48 pages

Updated analysis and forecasts based on Q1 2017 company-reported sales. Pharmavitae Analytics explores Astellas’s prescription pharmaceutical performance and outlook, encompassing corporate strategy, ...

  • United States
  • Japan
  • Type 2 Diabetes
  • Prescription Drug
  • Company research
  • Company

Akebia Therapeutics Inc (AKBA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 58 pages

Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients ...

  • Japan
  • Therapy
  • Chronic Disease
  • Company research
  • Company
  • Drug Approval

Thoratec Corporation - Medical Equipment - Deals and Alliances Profile, Global Data

  • $ 250
  • November 2016
  • 44 pages

Summary Thoratec Corp (Thoratec) is a medical device company. It undertakes the research, development, manufacture and marketing of proprietary medical devices used for mechanical circulatory support ...

  • World
  • Europe
  • Medical Device
  • Medical Equipment
  • Company research
  • Company

Arkray, Inc. - Medical Equipment - Deals and Alliances Profile, Global Data

  • $ 250
  • October 2016
  • 21 pages

Summary Arkray, Inc. (Arkray), formerly KDK Corporation is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis ...

  • World
  • APAC
  • Diagnostics
  • Medical Device
  • Company research
  • Company

Aerocrine AB – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • March 2016
  • 53 pages

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Sweden
  • Germany
  • Pharmaceutical
  • Asthma
  • Quarterly report
  • Company
  • Dates Price


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on